Literature DB >> 20568971

Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis.

Timo Rath1, Martin Roderfeld, Jörg Michael Halwe, Annette Tschuschner, Elke Roeb, Jürgen Graf.   

Abstract

OBJECTIVE: Matrix metalloproteinases (MMPs) are considered the predominant proteases in the pathogenesis of mucosal ulcerations associated with inflammatory bowel disease (IBD). Whether the malignancy associated MMP-7 and MMP-13 or the recently cloned MMP-28 convey a certain meaning for intestinal homeostasis and pathogenesis of IBD is currently unknown. We therefore set off to analyze regulation patterns and cellular origins of these MMPs in mucosal tissues of patients with ulcerative colitis (UC).
MATERIAL AND METHODS: Biopsy samples of affected and healthy tissues were obtained from 35 Norwegian patients with UC. RNA was quantified by quantitative real-time polymerase chain reaction to study MMP gene expression in both pathological and healthy mucosal specimens. Cellular origins were determined by immunohistology using surrogate markers for inflammation, neovascularization, and epithelial structures. Protein expression of MMP-7 and MMP-13 was quantified using enzyme-linked immunosorbent assay.
RESULTS: MMP-7 and MMP-13 gene expression was significantly increased in UC affected colonic mucosa whereas MMP-28 showed a decreased expression in inflamed mucosa. Endothelial cells and infiltrating leukocytes were identified as the major cellular sources of MMP-7 and MMP-13 in UC. Enterocytes represented the major cellular source of MMP-28 in healthy and inflamed mucosa.
CONCLUSIONS: MMP-7 and MMP-13 expression in inflammatory and endothelial cells indicate a role of these MMPs for both colitis associated neoangiogenesis and inflammatory changes. Decreased MMP-28 expression in UC is most likely the result of colitis associated epithelial destruction and loss of cryptal architecture.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20568971     DOI: 10.3109/00365521.2010.499961

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  17 in total

1.  Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation.

Authors:  R E Vandenbroucke; I Vanlaere; F Van Hauwermeiren; E Van Wonterghem; C Wilson; C Libert
Journal:  Mucosal Immunol       Date:  2013-10-16       Impact factor: 7.313

2.  Matrix Metalloproteinase-13 as a Target for Suppressing Corneal Ulceration Caused by Pseudomonas aeruginosa Infection.

Authors:  Nan Gao; Ashok Kumar; Fu-Shin X Yu
Journal:  J Infect Dis       Date:  2015-01-13       Impact factor: 5.226

3.  CXCL10 suppression of hem- and lymph-angiogenesis in inflamed corneas through MMP13.

Authors:  Nan Gao; Xiaowei Liu; Jiayin Wu; Juan Li; Chen Dong; Xinyi Wu; Xiao Xiao; Fu-Shin X Yu
Journal:  Angiogenesis       Date:  2017-06-16       Impact factor: 9.596

Review 4.  Is there new hope for therapeutic matrix metalloproteinase inhibition?

Authors:  Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Nat Rev Drug Discov       Date:  2014-11-07       Impact factor: 84.694

5.  Matrix metalloproteinase-13 is regulated by toll-like receptor-9 in colorectal cancer cells and mediates cellular migration.

Authors:  Timo Rath; Julia Stöckle; Martin Roderfeld; Annette Tschuschner; Jürgen Graf; Elke Roeb
Journal:  Oncol Lett       Date:  2011-03-21       Impact factor: 2.967

6.  Induction of the Matrix Metalloproteinase 13 Gene in Bronchial Epithelial Cells by Interferon and Identification of its Novel Functional Polymorphism.

Authors:  Yoichi Mashimo; Mika Sakurai-Yageta; Misa Watanabe; Takayasu Arima; Yoshinori Morita; Yuzaburo Inoue; Kazuki Sato; Toshiyuki Nishimuta; Shuichi Suzuki; Hiroko Watanabe; Akira Hoshioka; Minako Tomiita; Akiko Yamaide; Yoichi Kohno; Yoshitaka Okamoto; Naoki Shimojo; Akira Hata; Yoichi Suzuki
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

7.  Presence of intestinal Mycobacterium avium subspecies paratuberculosis (MAP) DNA is not associated with altered MMP expression in ulcerative colitis.

Authors:  Timo Rath; Martin Roderfeld; Sonja Blöcher; Annika Rhode; Tina Basler; Ömer Akineden; Amir Abdulmawjood; Jörg M Halwe; Ralph Goethe; Michael Bülte; Elke Roeb
Journal:  BMC Gastroenterol       Date:  2011-04-08       Impact factor: 3.067

Review 8.  Matrix metalloproteinases in inflammatory bowel disease: an update.

Authors:  Shane O'Sullivan; John F Gilmer; Carlos Medina
Journal:  Mediators Inflamm       Date:  2015-04-08       Impact factor: 4.711

9.  Phenethylisothiocyanate alters site- and promoter-specific histone tail modifications in cancer cells.

Authors:  Yi Liu; Suvobrata Chakravarty; Moul Dey
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

10.  Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF.

Authors:  Roosmarijn E Vandenbroucke; Eline Dejonckheere; Filip Van Hauwermeiren; Sofie Lodens; Riet De Rycke; Elien Van Wonterghem; An Staes; Kris Gevaert; Carlos López-Otin; Claude Libert
Journal:  EMBO Mol Med       Date:  2013-05-30       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.